Usman, Baby Girl -.
HRN: 28-28-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/21/2025
12/28/2025
IV
55mg
OD
Neonatal Sepsis
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes